Author: Dr. Savatta
-
PCa Patients on HD Would Benefit from Early Kidney Transplantation – Renal and Urology News
However, study findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest that patients with prostate cancer (PCa) might be better served by undergoing transplantation instead of waiting two years to be declared cancer-free. via PCa Patients on HD Would Benefit from Early Kidney Transplantation – Renal and Urology News. This study…
-
Prostate Cancer Screening: Moving Beyond PSA – Renal and Urology News
In nearly 1,000 men undergoing initial or repeat biopsy, these investigators found that urinary PCA3 prior to a prostate biopsy improved the prediction of PCa and high-grade disease with a high positive predictive value 90% in the initial biopsy setting and a high negative predictive value 88% in the repeat biopsy setting. The investigators conclude…
-
Robotic versus open distal ureteral reconstruction and reimplantation for benign stricture disease.
Four neocystostomies, four psoas hitches, and two Boari flaps were performed in the RAUR group. Estimated blood loss 30.6 vs 327.5 mL, P=0.001 and length of hospital stay 2.4 vs 5.1 d, P=0.01 were significantly reduced in the robotic group. Median BMI 29.4±5.3 vs 26.5±5.2, P=0.130 and operative time in minutes 306.6 vs 270.0 min,…
-
Prostate-Cancer Mortality at 11 Years of Follow-up — NEJM
After a median follow-up of 11 years in the core age group, the relative reduction in the risk of death from prostate cancer in the screening group was 21% rate ratio, 0.79; 95% confidence interval [CI], 0.68 to 0.91; P=0.001, and 29% after adjustment for noncompliance. The absolute reduction in mortality in the screening group…
-
PCA3 Test Okayed to Help Decide Need for Repeat Prostate Biopsy – Renal and Urology News
“Over-expression of the PCA3 gene is highly specific to cancerous prostate tissue,” John Wei, MD, MS, Professor of Urology at the University of Michigan Health System in Ann Arbor, said in a company-issued statement. “When evaluated with other risk factors, the PROGENSA PCA3 assay fills an important unmet clinical need by helping physicians identify which men…
-
5-ARI delays prostate cancer progression in men with low-risk disease – ModernMedicine
The 5-alpha-reductase inhibitor dutasteride Avodart appears to delay disease progression and the initiation of active treatment in men with low-risk, localized prostate cancer, results of a 3-year international clinical trial indicate.Treatment with dutasteride also reduces cancer-related anxiety, study authors found.”The results prove that using active surveillance plus dutasteride is a viable, safe, and effective treatment…
-
Couples Counseling Boosts Sex Lives After Prostate Cancer
But a new study finds that counseling helped married men and women figure out what sorts of treatments for erectile dysfunction worked for them and how to incorporate those methods during sex. In doing so, they returned some luster to their love lives. via Couples Counseling Boosts Sex Lives After Prostate Cancer. Couples often have…
-
Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes – Renal and Urology News
Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes via Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes – Renal and Urology News. Statins are medicines that are taken to lower cholesterol. Many studies have shown they are beneficial in preventing heart disease and many diseases. Some experts believe that these medicines help prevent…
-
After prostate surgery, some men leak during sex | Reuters
Incontinence during sex is a long-lasting problem for roughly one in eight men who have had their prostate removed due to cancer, a study of more than 1,400 patients has found. via After prostate surgery, some men leak during sex | Reuters. This article describes that some men will have loss of urine during sexual…